SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    G Visani, B Guiducci, C Giardini, F Loscocco, T Ricciardi, A Isidori, Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT, Bone Marrow Transplantation, 2014, 49, 4, 585

    CrossRef

  2. 2
    Sally B. Killick, Chris Carter, Dominic Culligan, Christopher Dalley, Emma Das-Gupta, Mark Drummond, Helen Enright, Gail L. Jones, Jonathan Kell, Juliet Mills, Ghulam Mufti, Jane Parker, Kavita Raj, Alexander Sternberg, Paresh Vyas, David Bowen, Guidelines for the diagnosis and management of adult myelodysplastic syndromes, British Journal of Haematology, 2014, 164, 4
  3. 3
    Bor-Sheng Ko, Cheng-Shyong Chang, Ming-Chih Chang, Tsai Yun Chen, Tzeon-Jye Chiou, Chang-Fang Chiu, Wen-Li Huang, Woei-Yau Kao, Yii-Jenq Lan, Shen-Fung Lin, Tran-Der Tan, Jih-Luh Tang, Cheng-Hwai Tzeng, Po-Nan Wang, Su-Pen Yet, Hwei-Fang Tien, Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement, International Journal of Hematology, 2014, 100, 1, 7

    CrossRef

  4. 4
    Philippe Armand, Haesook T. Kim, Johanna M. Virtanen, Riitta K. Parkkola, Maija A. Itälä-Remes, Navneet S. Majhail, Linda J. Burns, Todd DeFor, Bryan Trottier, Uwe Platzbecker, Joseph H. Antin, Martin Wermke, Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis, Biology of Blood and Marrow Transplantation, 2014, 20, 8, 1248

    CrossRef

  5. 5
    Takaaki Konuma, Seiko Kato, Maki Oiwa-Monna, Arinobu Tojo, Satoshi Takahashi, Pretransplant hyperferritinemia has no effect on the outcome of myeloablative cord blood transplantation for acute leukemia and myelodysplastic syndrome, Annals of Hematology, 2014, 93, 6, 1071

    CrossRef

  6. 6
    Drorit G Merkel, Arnon Nagler, Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes, Expert Review of Anticancer Therapy, 2014, 14, 7, 817

    CrossRef

  7. 7
    Glen A. Kennedy, Kirk L. Morris, Elango Subramonpillai, Cameron Curley, Jason Butler, Simon Durrant, A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia, British Journal of Haematology, 2013, 161, 6
  8. 8
    Uwe Platzbecker, Ghulam Mufti, Allogeneic stem cell transplantation in MDS: How? When?, Best Practice & Research Clinical Haematology, 2013, 26, 4, 421

    CrossRef

  9. 9
    B. J. Trottier, L. J. Burns, T. E. DeFor, S. Cooley, N. S. Majhail, Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content, Blood, 2013, 122, 9, 1678

    CrossRef

  10. 10
    P. Brissot, E. Bardou-Jacquet, M. Latournerie, L. Bridoux-Henno, A.-M. Jouanolle, O. Loréal, Enfermedades por sobrecarga de hierro en los niños, EMC - Pediatría, 2013, 48, 2, 1

    CrossRef

  11. 11
    B. N. Savani, Ferritin and FerriScan in HCT recipients, Blood, 2013, 122, 9, 1539

    CrossRef

  12. 12
    Philippe Armand, Hyperferritinemia in Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2013, 19, 3, 336

    CrossRef

  13. 13
    Pere Barba, David Valcárcel, José Antonio Pérez-Simón, Francesc Fernández-Avilés, José Luis Piñana, Rodrigo Martino, Lucía López-Anglada, Montserrat Rovira, Irene Garcia-Cadenas, Silvana Novelli, Enric Carreras, Lucía López Corral, Jorge Sierra, Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies, Biology of Blood and Marrow Transplantation, 2013, 19, 4, 597

    CrossRef

  14. 14
    Takayoshi Tachibana, Masatsugu Tanaka, Etsuko Yamazaki, Ayumi Numata, Hirotaka Takasaki, Hideyuki Kuwabara, Katsumichi Fujimaki, Rika Sakai, Hiroyuki Fujita, Shin Fujisawa, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori, Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant, Leukemia & Lymphoma, 2013, 54, 6, 1318

    CrossRef

  15. 15
    Andrew S. Artz, Koen van Besien, Pre-transplant serum ferritin is prognostic but is it useful?, Leukemia & Lymphoma, 2013, 54, 6, 1133

    CrossRef

  16. 16
    Sara C. Meyer, Alix O’Meara, Andreas S. Buser, André Tichelli, Jakob R. Passweg, Martin Stern, Prognostic Impact of Posttransplantation Iron Overload after Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2013, 19, 3, 440

    CrossRef

  17. 17
    Johanna M. Virtanen, Maija A. Itälä-Remes, Kari J. Remes, Tero Vahlberg, Jani P. Saunavaara, Marjatta Sinisalo, Riitta K. Parkkola, Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation, European Journal of Haematology, 2013, 91, 1
  18. 18
    P. Brissot, E. Bardou-Jacquet, M. Latournerie, L. Bridoux-Henno, A.-M. Jouanolle, O. Loréal, Surcharges en fer de l’enfant, EMC - Pédiatrie - Maladies infectieuses, 2013, 8, 1, 1

    CrossRef

  19. 19
    U. Platzbecker, Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights, Hematology, 2013, 2013, 1, 522

    CrossRef